Insulet (PODD) EPS (Diluted) Growth (1y) (2019 - 2026)
Insulet (PODD) EPS (Diluted) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 13.96% |
| 10 | Insulet | 10.31 Bn | 9.78 Bn | 562.60 Mn | 329.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 329.82% |
| Mar 31, 2026 | 170.91% |
| Dec 31, 2025 | 3.81% |
| Sep 30, 2025 | 18.30% |
| Jun 30, 2025 | -87.54% |
| Mar 31, 2025 | -31.41% |
| Dec 31, 2024 | -2.95% |
| Sep 30, 2024 | 48.67% |
| Jun 30, 2024 | 556.58% |
| Mar 31, 2024 | 105.69% |
| Dec 31, 2023 | 477.48% |
| Sep 30, 2023 | 1,041.06% |
| Jun 30, 2023 | 177.13% |
| Mar 31, 2023 | -14.68% |
| Dec 31, 2022 | -42.89% |
| Sep 30, 2022 | -141.39% |
| Jun 30, 2022 | -34.63% |
| Dec 31, 2021 | 264.20% |
| Sep 30, 2021 | 4.27% |
| Jun 30, 2021 | -270.70% |